Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has experienced a shift in its substantial holdings as KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have ceased to be major shareholders as of October 24, 2024. This change in shareholding dynamics may stir interest among investors monitoring the company’s market position and stock performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.